Parallax Health Sciences Inc. announced earnings results for the first quarter ended March 31, 2019. For the first quarter, the company announced sales was USD 50,990 compared to USD 4,890 a year ago. Operating loss was USD 1.410 million compared to USD 1.951 million a year ago. Net loss was USD 1.674 million compared to USD 3.856 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.025 a year ago. Diluted loss per share from continuing operations was USD 0.007 compared to USD 0.017 a year ago.